Invesco Ltd. · IVZ · FY2026 Q2 · Calendar Q3 2026

Invesco: Record inflows support higher margins and product expansion

The supplied Q2 analysis supports a constructive operating thesis for Invesco: record inflows, ETF demand, product launches, partnerships, and operating leverage are reinforcing growth. That thesis remains conditional on sustaining flows and margins while managing fee compression and hybrid-platform execution.

Reported Before market openNYSEFinancial Services $13.63B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.71 Consensus $0.67
EPS surprise +6.6% Reported versus consensus
Reported revenue $1.33B Consensus $1.32B
Revenue surprise +0.8% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -2.3% Event window
SPY move +0.2% Same window
Abnormal move -2.5% Stock minus SPY
Volume 1.8× Versus trailing sessions
Subsequent drift +11.2% Up to 20 sessions
IVZSPY benchmark

Ask FN2 about IVZ FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior-quarter analysis, the supplied Q2 analysis describes stronger inflows, a higher operating margin, continued QQQ international expansion, more than 50 new products launched during the year, and new tokenized-Treasury and Canadian sub-advisory developments. The focus also shifted toward sustaining high-30s margins while completing the hybrid-platform rollout.

Guidance delta

Management guidance sentiment was maintained; the supplied analysis highlights a sustained high-30s operating-margin target and continued platform and product expansion.

Key takeaways

  • Record net long-term inflows and higher assets under management indicate broad demand across regions and products.
  • ETF demand, particularly in the QQQ franchise, remained the central growth engine in the supplied analysis.
  • Operating-margin expansion and balance-sheet deleveraging strengthen the operating backdrop.
  • New products and partnerships broaden exposure to active ETFs, tokenized Treasuries, private markets, and international distribution.
  • The main offsets are fee compression, flow volatility, platform implementation costs, and private-market risk.

Management priorities

  • Expand the QQQ franchise internationally and through product extensions.
  • Launch additional active ETFs and continue the BulletShares rollout.
  • Complete the hybrid investment platform implementation and pursue related cost efficiencies.
  • Deepen partnerships and sub-advisory relationships across private markets and international channels.
  • Maintain capital returns through buybacks and dividends.

Follow IVZ with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
IVZ EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 3 future estimate-only quarters. Q1 '24 estimate $0.40 Q1 '24 actual $0.33, miss Q2 '24 estimate $0.40 Q2 '24 actual $0.43, beat Q3 '24 estimate $0.44 Q3 '24 actual $0.44, match Q2 '25 estimate $0.41 Q2 '25 actual $0.36, miss Q3 '25 estimate $0.45 Q3 '25 actual $0.61, beat Q4 '25 estimate $0.58 Q4 '25 actual $0.62, beat Q1 '26 estimate $0.58 Q1 '26 actual $0.57, match Q2 '26 estimate $0.67 Q2 '26 actual $0.71, beat Q3 '26 estimate $0.74 Q4 '26 estimate $0.81 Q1 '27 estimate $0.72
Show 1 more >

Analyst Consensus ?

ConsensusHold28 ratings
Bullish1242.9%
Neutral1657.1%
Bearish00.0%

Analyst 52W Price Targets

$30.74Current
$17Low
$28.67Average
$39High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 24, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Evercore ISI Group In Line In LineMaintainSep 9, 2026
TD Cowen Buy BuyMaintainAug 13, 2026
RBC Capital Outperform OutperformMaintainJul 29, 2026
JP Morgan Neutral NeutralMaintainJul 29, 2026
Barclays Equal Weight Equal WeightMaintainJul 29, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJul 17, 2026
Goldman Sachs Neutral NeutralMaintainApr 29, 2026
BMO Capital Outperform OutperformMaintainApr 10, 2026
Argus Research Buy BuyMaintainJan 28, 2026
Deutsche Bank Buy HoldUpgradeDec 17, 2025
B of A Securities Neutral NeutralMaintainOct 2, 2025
Citigroup Neutral NeutralMaintainSep 29, 2025
Wells Fargo Equal Weight UnderweightUpgradeJul 11, 2025
UBS Neutral NeutralMaintainFeb 3, 2025
Keefe, Bruyette & Woods Market Perform Market PerformMaintainJan 29, 2025
Credit Suisse Neutral UnderperformUpgradeMar 29, 2023
Jefferies Hold BuyDowngradeJun 7, 2019
Keefe Bruyette & Woods Market Perform OutperformDowngradeJul 13, 2018
Argus Buy BuyMaintainMay 5, 2018
Bank of America Neutral BuyDowngradeJan 8, 2018
Keefe, Bruyette& Woods Perform OutperformDowngradeDec 12, 2016
Susquehanna Positive PositiveMaintainSep 3, 2015
PiperJaffray Overweight OverweightMaintainJun 3, 2015
Sterne Agee Buy NeutralUpgradeJan 7, 2015
Evercore Partners Equal Weight Equal WeightMaintainJul 10, 2013
Nomura Buy BuyMaintainMay 1, 2013
Stifel Nicolaus Buy BuyMaintainFeb 1, 2013
Stifel Buy BuyMaintainFeb 1, 2013
Show less

Named analyst price targets

Upside is calculated against the persisted current price $30.74. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
RBC CapitalAnalyst unavailable$39$32.02 +26.9%Aug 13, 2026
Evercore ISIAnalyst unavailable$35$32.05 +13.9%Aug 10, 2026
BarclaysAnalyst unavailable$32$29.43 +4.1%Jul 29, 2026
BarclaysAnalyst unavailable$31$28.4 +0.8%Jul 14, 2026
Evercore ISIAnalyst unavailable$32$29.08 +4.1%Jul 10, 2026
Evercore ISIAnalyst unavailable$31$27.79 +0.8%Jun 8, 2026
Goldman SachsAlexander Blostein$30$25.88 -2.4%Apr 29, 2026
BarclaysAnalyst unavailable$26$25.88 -15.4%Apr 29, 2026
RBC CapitalKenneth Lee$31$24.95 +0.8%Apr 21, 2026
Evercore ISIAnalyst unavailable$27$23.63 -12.2%Apr 10, 2026
BMO CapitalAnalyst unavailable$28$23.63 -8.9%Apr 10, 2026
RBC CapitalKenneth Lee$33$27.76 +7.4%Jan 28, 2026
Cowen & Co.Analyst unavailable$34.5$27.28 +12.2%Jan 28, 2026
Argus ResearchStephen Biggar$31$27.26 +0.8%Jan 28, 2026
Goldman SachsAnalyst unavailable$29.5$27.16 -4.0%Jan 28, 2026
BarclaysAnalyst unavailable$29$27.16 -5.7%Jan 28, 2026
Morgan StanleyAnalyst unavailable$29$28.4 -5.7%Jan 26, 2026
RBC CapitalKenneth Lee$35$28.95 +13.9%Jan 21, 2026
Goldman SachsAlexander Blostein$28.75$28.25 -6.5%Jan 15, 2026
BarclaysBenjamin Budish$30$28.25 -2.4%Jan 15, 2026
Goldman SachsAlexander Blostein$28.25$28.16 -8.1%Jan 6, 2026
Morgan StanleyAnalyst unavailable$28$26.82 -8.9%Dec 17, 2025
Deutsche BankAnalyst unavailable$31$26.03 +0.8%Dec 17, 2025
BarclaysBenjamin Budish$28$26.99 -8.9%Dec 12, 2025
BMO CapitalAnalyst unavailable$30$26.54 -2.4%Dec 10, 2025
Goldman SachsAnalyst unavailable$25.5$23.81 -17.0%Nov 25, 2025
Fundamental ResearchAnalyst unavailable$27$23.66 -12.2%Oct 31, 2025
RBC CapitalKenneth Lee$25$24.02 -18.7%Oct 30, 2025
Goldman SachsAnalyst unavailable$26.5$24.35 -13.8%Oct 29, 2025
BarclaysAnalyst unavailable$24$22.84 -21.9%Oct 21, 2025
Morgan StanleyAnalyst unavailable$26$23.98 -15.4%Oct 6, 2025
Evercore ISIGlenn Schorr$24$21.99 -21.9%Sep 5, 2025
Wells FargoMichael Brown$18$17.43 -41.4%Jul 11, 2025
BarclaysBenjamin Budish$19$18.04 -38.2%Oct 23, 2024
Wells FargoMichael Brown$16$15.8 -48.0%Sep 11, 2024
RBC CapitalKenneth Lee$16$14.52 -48.0%Apr 25, 2024
Deutsche BankBrian Bedell$17$16.53 -44.7%Apr 5, 2024
Morgan StanleyAnalyst unavailable$23$18.96 -25.2%Apr 27, 2022
Deutsche BankBrian Bedell$24$19.03 -21.9%Apr 27, 2022
Morgan StanleyAnalyst unavailable$25$20.39 -18.7%Apr 25, 2022
RBC CapitalKenneth Lee$23$21.41 -25.2%Jan 24, 2022
BarclaysJeremy Campbell$25$26.29 -18.7%Apr 30, 2021
Argus ResearchStephen Biggar$33$26.51 +7.4%Apr 28, 2021
Wells FargoChristopher Harris$25$25.23 -18.7%Apr 13, 2021
Show less

Track every rating change on IVZ the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Invesco Ltd. engages in the investment management business. Its products include mutual funds, unit trusts, exchange-traded funds, closed-end funds, and retirement plans. The company was founded in December 1935 and is headquartered in Atlanta, GA.

Historical context

All IVZ earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the IVZ recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-28T15:03:54.450010+00:00
  2. FN2 earnings calendar · 2026-09-02T01:23:14.593608+00:00
  3. Polygon adjusted daily market bars · 2026-09-24T03:20:56.090675+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-24T03:20:56.087459+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-24. For educational purposes only; not investment advice.